-

Cutera to Participate in Maxim Group’s “Re-Engaging Medical Practices in an Era of COVID-19” Webinar

BRISBANE, Calif.--(BUSINESS WIRE)--Cutera, Inc. (CUTR) (“Cutera” or the “Company”), a leading provider of laser and other energy-based aesthetic systems for practitioners worldwide, today announced that Dave Mowry, Chief Executive Officer, will participate in a panel discussion as part of the Re-Engaging Medical Practices in an Era of COVID-19 webinar, presented by Maxim Group and M-Vest, at 11:00 a.m. ET on Thursday, July 16, 2020.

The panel discussion will be webcast and can be accessed from the Investor Relations section of Cutera’s website at http://www.cutera.com/.

About the Maxim Group’s Re-Engaging Medical Practices in an Era of COVID-19 Webinar

As the country slowly begins to re-open, information is imperative. How and when will medical practices re-open, and to what extent? How are companies adjusting their commercialization strategies and practices during this time? What does access to capital look like in a reopening world? This conference intends to explore these questions and more, with insights from management, Q&A, and panel discussions.

To access the full event, please RSVP HERE.

About Cutera, Inc.

Brisbane, California-based Cutera is a leading provider of laser and other energy-based aesthetic systems for practitioners worldwide. Since 1998, Cutera has been developing innovative, easy-to-use products that enable physicians and other qualified practitioners to offer safe and effective aesthetic treatments to their patients. For more information, call 1-888-4CUTERA or visit www.cutera.com.

Contacts

Cutera, Inc.
Anne Werdan
Director, Investor Relations
415-657-5500
awerdan@cutera.com

Industry:

Cutera, Inc.

NASDAQ:CUTR
Details
Headquarters: Brisbane, CA
CEO: Taylor Harris
Employees: 450
Organization: PUB
Revenues: $252 million (2022)
Net Income: NM (2022)
Release Versions
English

Contacts

Cutera, Inc.
Anne Werdan
Director, Investor Relations
415-657-5500
awerdan@cutera.com

More News From Cutera, Inc.

Cutera® Successfully Completes Restructuring Transaction and Moves Forward with Enhanced Capital Structure

BRISBANE, Calif.--(BUSINESS WIRE)--CUTERA, INC., (“Cutera” or “the Company”), a leading provider of aesthetic and dermatology solutions, today announced that the Company has successfully completed its financial restructuring process and emerged from Chapter 11. Cutera emerges with a significantly stronger balance sheet, well positioned to drive innovation and growth. Through this process, Cutera has reduced its debt by nearly $400 million, or over 90%, and raised $65 million in new money financ...

Cutera Announces Voluntarily Delisting from Nasdaq

BRISBANE, Calif.--(BUSINESS WIRE)--Cutera, Inc. (“Cutera” or the “Company”) (Nasdaq: CUTR) today announced that it has formally notified The Nasdaq Stock Market LLC (“Nasdaq”) of its intent to voluntarily delist its common stock from the Nasdaq Global Select Market. Cutera expects to file a Form 25 with the Securities and Exchange Commission (the "SEC") relating to the voluntary delisting of its common stock on or about March 20, 2025. The Company expects the delisting of the common stock to be...

Cutera Takes Steps to Strengthen Financial Foundation and Position the Company for Long-Term Success

BRISBANE, Calif.--(BUSINESS WIRE)--CUTERA, INC., (“Cutera” or “the Company”), a leading provider of aesthetic and dermatology solutions, today announced that it is initiating a restructuring transaction with the support of a group of existing lenders, representing approximately 74% of the Company’s notes, to strengthen its balance sheet and position Cutera for long-term success. Through the transaction, Cutera will reduce its debt by nearly $400 million, or over 90%, and raise $65 million in ne...
Back to Newsroom